Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Treatment of the Bradycardia-Tachycardia Syndrome with Low Doses of Amiodarone

      ,

      Cardiology

      S. Karger AG

      Amiodarone, Bradycardia-tachycardia syndrome, Low doses

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          4 patients with the bradycardia-tachycardia syndrome have been treated for 4–13 months with amiodarone at a daily dose of 200 mg for 5–6 days every week. After this treatment was started neither episodes of tachyarrhythmia nor symptomatic bradycardia occurred. Corneal microdeposits without interference with vision were observed in 2 patients, 6 and 7 months after the start of treatment. A trial with low doses of amiodarone could be useful in patients suffering from bradycardia-tachycardia syndrome, before deciding for permanent cardiac pacemaker implantation.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1981
          1981
          07 November 2008
          : 68
          : 2
          : 118-123
          Affiliations
          II Divisione Medicina Interna, Ospedale Generale ‘F. Lotti’, Pontedera, Pisa, Italia
          Article
          173270 Cardiology 1981;68:118–123
          10.1159/000173270
          7023674
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Categories
          Original Paper

          Comments

          Comment on this article